’ s response to reviews Title : Addition of nucleoside analogues to Peg-IFNα-2 a enhances virological response in chronic hepatitis B patients without early response to Peg-IFNα-2 a : A randomized controlled trial

Title: Addition of nucleoside analogues to Peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to Peg-IFNα-2a: A randomized controlled trial Authors: yan xu (zrlxuyan@163.com) xu wang (zrlwangxu@163.com) zhenhua liu (sdlzh410@163.com) Changyu Zhou (doczcy@163.com) wenqian qi (qiwenqian_0@163.com) jian jiao (zrljiaojian@163.com) fan yu (yu-fan001@163.com) honghua guo (soyguo@163.com) ping zhao (dr.zhaoping@163.com) Jiangbin Wang (zrlwangjb@medmail.com.cn) Version: 3 Date: 17 Apr 2017 Author’s response to reviews: Replies to recommendations on revision 1. We notice the removal of author Jian Jiao since original submission of the manuscript. In line with COPE guidelines, BioMed Central requires written confirmation from all authors that they agree with any proposed changes in authorship of submitted manuscripts or published articles. In such cases, we use a standardised form which we would request you and your co-authors to complete (including the removed author).